ロード中...
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study
BACKGROUND: In the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study, Cladribine Tablets significantly improved clinical and magnetic resonance imaging (MRI) outcomes (vs placebo) in patients with relapsing-remitting multiple sclerosis. OBJECTIVE: Describe two clinically relevant...
保存先:
| 出版年: | Mult Scler |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6460686/ https://ncbi.nlm.nih.gov/pubmed/29716436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458518771875 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|